Envestnet Asset Management Inc. grew its stake in The Cooper Companies, Inc. (NYSE:COO) by 9.2% in the fourth quarter, Holdings Channel reports. The institutional investor owned 10,113 shares of the medical device company’s stock after buying an additional 850 shares during the period. Envestnet Asset Management Inc.’s holdings in The Cooper Companies were worth $2,205,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors also recently bought and sold shares of the business. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp raised its holdings in shares of The Cooper Companies by 7.0% in the fourth quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 21,374 shares of the medical device company’s stock worth $4,657,000 after buying an additional 1,395 shares during the last quarter. We Are One Seven LLC purchased a new position in shares of The Cooper Companies in the fourth quarter worth $351,000. Banco de Sabadell S.A purchased a new position in shares of The Cooper Companies in the fourth quarter worth $979,000. BB&T Investment Services Inc. raised its holdings in shares of The Cooper Companies by 71.0% in the fourth quarter. BB&T Investment Services Inc. now owns 542 shares of the medical device company’s stock worth $119,000 after buying an additional 225 shares during the last quarter. Finally, MetLife Investment Advisors LLC purchased a new position in shares of The Cooper Companies in the fourth quarter worth $3,300,000. 98.53% of the stock is owned by institutional investors and hedge funds.
In other The Cooper Companies news, EVP Carol R. Kaufman sold 13,362 shares of The Cooper Companies stock in a transaction on Monday, March 12th. The shares were sold at an average price of $243.88, for a total value of $3,258,724.56. Following the completion of the transaction, the executive vice president now owns 59,305 shares of the company’s stock, valued at $14,463,303.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Allan E. Rubenstein sold 6,450 shares of The Cooper Companies stock in a transaction on Friday, January 12th. The shares were sold at an average price of $228.79, for a total transaction of $1,475,695.50. Following the completion of the transaction, the director now directly owns 8,628 shares of the company’s stock, valued at approximately $1,974,000.12. The disclosure for this sale can be found here. Insiders sold 56,581 shares of company stock valued at $13,645,387 in the last ninety days. 1.60% of the stock is owned by corporate insiders.
The Cooper Companies (NYSE:COO) last released its quarterly earnings data on Thursday, March 8th. The medical device company reported $2.79 earnings per share for the quarter, beating analysts’ consensus estimates of $2.51 by $0.28. The Cooper Companies had a net margin of 7.83% and a return on equity of 16.90%. The company had revenue of $590.00 million during the quarter, compared to analysts’ expectations of $583.07 million. During the same quarter in the previous year, the company earned $1.93 earnings per share. The firm’s revenue for the quarter was up 18.2% on a year-over-year basis. equities analysts anticipate that The Cooper Companies, Inc. will post 11.83 EPS for the current year.
A number of research analysts have issued reports on the stock. Goldman Sachs began coverage on shares of The Cooper Companies in a report on Wednesday. They issued a “neutral” rating and a $231.00 price target for the company. Oppenheimer set a $265.00 target price on shares of The Cooper Companies and gave the stock a “hold” rating in a report on Thursday, March 29th. TheStreet cut shares of The Cooper Companies from a “b” rating to a “c” rating in a report on Thursday, March 8th. BMO Capital Markets reissued an “outperform” rating and set a $280.00 target price (up previously from $277.00) on shares of The Cooper Companies in a report on Friday, March 9th. Finally, Stephens reissued a “hold” rating and set a $270.00 target price on shares of The Cooper Companies in a report on Friday, March 9th. Nine research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $264.18.
TRADEMARK VIOLATION WARNING: This piece was posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this piece can be read at https://www.tickerreport.com/banking-finance/3340184/the-cooper-companies-inc-coo-shares-bought-by-envestnet-asset-management-inc.html.
About The Cooper Companies
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NYSE:COO).
Receive News & Ratings for The Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.